American Association for Cancer Research
Browse
10780432ccr141403-sup-132514_2_supp_2857147_njkcld.pdf (1.37 MB)

Supplementary Fig. S2 from Global Transcriptional Changes Following Statin Treatment in Breast Cancer

Download (1.37 MB)
journal contribution
posted on 2023-03-31, 18:18 authored by Olöf Bjarnadottir, Siker Kimbung, Ida Johansson, Srinivas Veerla, Mats Jönsson, Pär-Ola Bendahl, Dorthe Grabau, Ingrid Hedenfalk, Signe Borgquist

Supplementary Fig. S2. RT-qPCR validation of the expression of five selected genes. A) Expression of HMGCR, DUSP1, RHOB, JUN and FOS measured by microarray and RT-qPCR respectively. B) Change in HMGCR expression in all patients by RT-qPCR.

History

ARTICLE ABSTRACT

Background: Statins purportedly exert antitumoral effects, but the underlying mechanisms are currently not fully elucidated. The aim of this study was to explore potential statin-induced effects on global gene expression profiles in primary breast cancer.Experimental Design: This window-of-opportunity phase II trial enrolled 50 newly diagnosed breast cancer patients prescribed atorvastatin (80 mg/day) for 2 weeks presurgically. Pre- and posttreatment tumor samples were analyzed using Significance Analysis of Microarrays (SAM) to identify differentially expressed genes. Similarly, SAM and gene ontology analyses were applied to gene expression data derived from atorvastatin-treated breast cancer cell lines (MCF7, BT474, SKBR3, and MDAMB231) comparing treated and untreated cells. The Systematic Motif Analysis Retrieval Tool (SMART) was used to identify enriched transcription factor-binding sites. Literature Vector Analysis (LitVAn) identified gene module functionality, and pathway analysis was performed using GeneGo Pathways Software (MetaCore; https://portal.genego.com/).Results: Comparative analysis of gene expression profiles in paired clinical samples revealed 407 significantly differentially expressed genes (FDR = 0); 32 upregulated and 375 downregulated genes. Restricted filtration (fold change ≥1.49) resulted in 21 upregulated and 46 downregulated genes. Significantly upregulated genes included DUSP1, RHOB1, GADD45B, and RGS1. Pooled results from gene ontology, LitVAn and SMART analyses identified statin-induced effects on the apoptotic and MAPK pathways among others. Comparative analyses of gene expression profiles in breast cancer cell lines showed significant upregulation of the mevalonate and proapoptotic pathways following atorvastatin treatment.Conclusions: We report potential statin-induced changes in global tumor gene expression profiles, indicating MAPK pathway inhibition and proapoptotic events. Clin Cancer Res; 21(15); 3402–11. ©2015 AACR.